Quantitation of retinal ablation in proliferative diabetic retinopathy (Q36708149)

15 August 2017

title

Quantitation of retinal ablation in proliferative diabetic retinopathy (English)

1 reference

15 August 2017

Reddy VM

1

1 reference

15 August 2017

Zamora RL

series ordinal

2

1 reference

15 August 2017

Olk RJ

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

American Journal of Ophthalmology

15 August 2017

published in

1 reference

15 August 2017

volume

119

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

760-766

1 reference

Proliferative diabetic retinopathy: treatment with xenon-arc photocoagulation. Interim report of multicentre randomised controlled trial

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Cryopexy treatment of proliferative diabetic retinopathy. Retinal cryoablation in patients with severe vitreous hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Transconjunctival anterior retinal cryotherapy for proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Bjerrum lecture. Treatment of diabetic retinopathy with photocoagulation. Results of photocoagulation therapy of proliferative retinopathy in childhood-onset and maturity-onset diabetes and an approach to the dosage in photocoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Macular Edema after Scatter Laser Photocoagulation for Proliferative Diabetic Retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

inferred from DOI database lookup

7 January 2021

based on heuristic

The efficacy of additional argon laser photocoagulation for persistent, severe proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Augmentation laser for proliferative diabetic retinopathy that fails to respond to initial panretinal photocoagulation

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)72782-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9394(14)72782-5

1 reference

15 August 2017

1 reference